Literature DB >> 8252807

Genes on the X chromosome affect development of collagen-induced arthritis in mice.

L Jansson1, R Holmdahl.   

Abstract

Susceptibility to collagen-induced arthritis (CIA) in mice is associated with a class II gene in MHC (Aq) but also with unknown genes outside MHC. Investigated here is the influence of genes on the X chromosome as well as the role of the X-linked immunodeficiency (xid) mutation. Reciprocal male F1 hybrids, bred to be heterozygous or homozygous for Aq, showed a genetic influence in their susceptibility to develop CIA. Crosses were made between B10.G, B10.Q, DBA/1, SWR/J, C3H.Q and CBA/Ca, and all F1 mice were castrated to avoid sex hormone modulation of the susceptibility. A differential timing of arthritis onset and severity were seen in the reciprocal F1 males. An exception was the reciprocal F1 male offspring from SWR/J and DBA/1 crosses which differed only in disease severity late in the course of the disease. The female F1 crosses did not show the same pattern of differential susceptibility to CIA as the F1 males. To exclude the possible influence of the Y chromosome, F1 males of reciprocal crosses were back-crossed to the parental strains creating offspring with equal X chromosomes but divergent Y chromosomes. No difference in development of arthritis was observed in these. The influence of the xid mutation was investigated next. The xid loci from the CBA/N mouse was bred into DBA/1 strain which is highly susceptible to CIA. The resulting congenic DBA/1-xid strain was resistant to induction of CIA and did not develop an antibody response to type II collagen. We conclude that polymorphic genes on the X chromosome modulate susceptibility to CIA. The results from the experiments with mice carrying xid mutations confirm that such immune modulating genes exist on the sex chromosomes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252807      PMCID: PMC1534441          DOI: 10.1111/j.1365-2249.1993.tb08218.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

Review 1.  The human immune response region (HLA-D) and disease susceptibility.

Authors:  P Stastny; E J Ball; P J Dry; G Nunez
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

2.  High sensitivity to androgen as a contributing factor in sex differences in the immune response.

Authors:  D A Cohn
Journal:  Arthritis Rheum       Date:  1979-11

Review 3.  CBA/N immune defective mice; evidence for the failure of a B cell subpopulation to be expressed.

Authors:  I Scher
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

4.  Differential expression of steroid sulphatase locus on active and inactive human X chromosome.

Authors:  B R Migeon; L J Shapiro; R A Norum; T Mohandas; J Axelman; R L Dabora
Journal:  Nature       Date:  1982-10-28       Impact factor: 49.962

5.  CBA/N X-linked defect delays expression of the Y-linked accelerated autoimmune disease in BXSB mice.

Authors:  B Golding; H Golding; P G Foiles; J I Morton
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

6.  Immunisation against heterologous type II collagen induces arthritis in mice.

Authors:  J S Courtenay; M J Dallman; A D Dayan; A Martin; B Mosedale
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

7.  Lymphocytes alloantigens associated with X-chromosome-linked immune response genes.

Authors:  M Zeicher; E Mozes; P Lonai
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

8.  Serum transfer of collagen-induced arthritis in mice.

Authors:  J M Stuart; F J Dixon
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

9.  Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates.

Authors:  P H Wooley; H S Luthra; J M Stuart; C S David
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Phosphorylcholine-specific helper T cells in mice with an X-linked defect of antibody production to the same hapten.

Authors:  R B Kaplan; J Quintáns
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  23 in total

1.  Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.

Authors:  Aditya Sharma; B K Thelma
Journal:  J Mol Model       Date:  2019-06-06       Impact factor: 1.810

Review 2.  B cells as effectors and regulators of sex-biased arthritis.

Authors:  David Luckey; Kay Medina; Veena Taneja
Journal:  Autoimmunity       Date:  2012-08       Impact factor: 2.815

3.  The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy.

Authors:  Lee A Honigberg; Ashley M Smith; Mint Sirisawad; Erik Verner; David Loury; Betty Chang; Shyr Li; Zhengying Pan; Douglas H Thamm; Richard A Miller; Joseph J Buggy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

Review 4.  The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.

Authors:  Leslie J Crofford; Lindsay E Nyhoff; Jonathan H Sheehan; Peggy L Kendall
Journal:  Expert Rev Clin Immunol       Date:  2016-03-04       Impact factor: 4.473

5.  Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis.

Authors:  Julie A Di Paolo; Tao Huang; Mercedesz Balazs; James Barbosa; Kai H Barck; Brandon J Bravo; Richard A D Carano; James Darrow; Douglas R Davies; Laura E DeForge; Lauri Diehl; Ronald Ferrando; Steven L Gallion; Anthony M Giannetti; Peter Gribling; Vincent Hurez; Sarah G Hymowitz; Randall Jones; Jeffrey E Kropf; Wyne P Lee; Patricia M Maciejewski; Scott A Mitchell; Hong Rong; Bart L Staker; J Andrew Whitney; Sherry Yeh; Wendy B Young; Christine Yu; Juan Zhang; Karin Reif; Kevin S Currie
Journal:  Nat Chem Biol       Date:  2010-11-28       Impact factor: 15.040

Review 6.  Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications.

Authors:  Sabrina Solouki; Avery August; Weishan Huang
Journal:  Pharmacol Ther       Date:  2019-05-11       Impact factor: 12.310

Review 7.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

8.  Bruton's Tyrosine Kinase Deficiency Inhibits Autoimmune Arthritis in Mice but Fails to Block Immune Complex-Mediated Inflammatory Arthritis.

Authors:  Lindsay E Nyhoff; Bridgette L Barron; Elizabeth M Johnson; Rachel H Bonami; Damian Maseda; Benjamin A Fensterheim; Wei Han; Timothy S Blackwell; Leslie J Crofford; Peggy L Kendall
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

9.  Ankylosing spondylitis in a patient with Turner syndrome: a case report.

Authors:  Onur Armagan; Ayse Ekim; Arzu Dinc; Cengiz Oner
Journal:  Rheumatol Int       Date:  2007-04-19       Impact factor: 2.631

Review 10.  Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.

Authors:  Stefan F H Neys; Rudi W Hendriks; Odilia B J Corneth
Journal:  Front Cell Dev Biol       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.